Abstract
Background
Oral isotretinoin has traditionally been prescribed only in secondary care for severe or resistant acne.
Aims
To explore whether this drug can be safely initiated and monitored in primary care by a GP with extra training in dermatology.
Method
One hundred consecutive patients who were started on oral isotretinoin therapy in a primary care centre were retrospectively reviewed.
Results
One hundred percent of the patients with acne who completed their course of isotretinoin were cleared at the end of treatment. Twenty-three of the eighty-one patients (28%) who were followed-up after a mean of 5 years relapsed and eighteen (22%) had to have at least one more course of isotretinoin. Seventy-four of seventy-seven (96%) patients who had long-term follow-up were satisfied with the level of care they received in primary care.
Conclusion
This study suggests that oral isotretinoin can be safely initiated and monitored by a GP with a special interest in dermatology and experience in prescribing systemic retinoids.
Similar content being viewed by others
References
Dawson AL, Dellavalle RP (2013) Acne vulgaris. BMJ 346:f2634
Bhate K, Williams HC (2013) Epidemiology of acne vulgaris. Br J Dermatol 168(3):474–485
Marqueling AL, Zane LT (2007) Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 26(4):210–220
Ayer J, Burrows N (2006) Acne: more than skin deep. Postgrad Med J 82(970):500–506
Mallon E, Newton JN, Klassen A et al (1999) The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140(4):672–676
Zomerdijk IM, Ruiter R, Houweling LMA et al (2014) Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. BMJ Open 4(11):e005602. doi:10.1136/bmjopen-2014-005602
Kontaxakis VP, Skourides D, Ferentinos P et al (2009) Isotretinoin and psychopathology: a review. Ann Gen Psychiatry 8:2. doi:10.1186/1744-859X-8-2
Magin P, Pond D, Smith W (2005) Isotretinoin, depression and suicide: a review of the evidence. Br J Gen Pract 55(511):134–138
Goodfield MJD, Cox NH, Bowser A et al (2010) Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. Br J Dermatol 162(6):1172–1179. doi:10.1111/j.1365-2133.2010.09836.x
https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA0050-053-004_24072015121051.pdf. Accessed 7 Jan 2017
Layton AM, Knaggs H, Taylor J, Cunliffe WJ (1993) Isotretinoin for acne vulgaris-10 years later; a safe and successful treatment. Br J Dermatol 129:292–296
Azoulay L, Oraichi D, Bérard A (2007) Isotretinoin therapy and the incidence of acne relapse: a nested case–control study. Br J Dermatol 157(6):1240–1248 Epub 2007 Oct 26
Buckley D, Rogers S, Daly P (1990) Isotretinoin therapy for acne vulgaris: results in an Irish population. Ir J Med Sci 159(1):2–5
Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857–872
Tenner S (2014) Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. Am J Gastroenterol 109(4):570–571. doi:10.1038/ajg.2014.34
http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Isotretinoin_29/WC500010881.pdf. Accessed 7 Jan 2017
Acknowledgements
We would like to thank all our patients who co-operated with us in completing this important work. We would also like to Tadhg O’ Shea (Institute of Technology, Tralee) who assisted with statistical analysis. Finally, we would like to thank our local GP colleagues who entrusted their patients to our care for the management of their troublesome acne.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This was obtained from the Clinical Research and Ethics Committee, University College Cork, Ireland.
Informed consent
Informed consent was obtained from all individual participants in the study.
Rights and permissions
About this article
Cite this article
Buckley, D., Yoganathan, S. Can oral isotretinoin be safely initiated and monitored in primary care? A case series. Ir J Med Sci 186, 315–319 (2017). https://doi.org/10.1007/s11845-016-1540-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1540-5